FOLFOXIRI—improving outcomes of metastatic colorectal cancer

被引：0
|
作者：
Alessia Errico
机构：
来源：
Nature Reviews Clinical Oncology | 2014年 / 11卷 / 12期
关键词：
D O I：
10.1038/nrclinonc.2014.194
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：684 / 684
相关论文
共 50 条
  • [1] FOLFOXIRI and bevacizumab in metastatic colorectal cancer
    Rahman, Ahmadur
    [J]. LANCET ONCOLOGY, 2014, 15 (13): : E590 - E590
  • [2] FOLFOXIRI reintroduction in metastatic colorectal cancer
    Glynne-Jones, Rob
    Harrison, Mark
    [J]. LANCET ONCOLOGY, 2020, 21 (04): : 468 - 469
  • [3] FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
    Haines, Ian E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (03): : 290 - 291
  • [4] FOLFOXIRI plus Bevacizumab in metastatic colorectal Cancer
    不详
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (07): : 630 - 630
  • [5] Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
    Loupakis, Fotios
    Cremolini, Chiara
    Masi, Gianluca
    Lonardi, Sara
    Zagonel, Vittorina
    Salvatore, Lisa
    Cortesi, Enrico
    Tomasello, Gianluca
    Ronzoni, Monica
    Spadi, Rosella
    Zaniboni, Alberto
    Tonini, Giuseppe
    Buonadonna, Angela
    Amoroso, Domenico
    Chiara, Silvana
    Carlomagno, Chiara
    Boni, Corrado
    Allegrini, Giacomo
    Boni, Luca
    Falcone, Alfredo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (17): : 1609 - 1618
  • [6] REINTRODUCTION OF FOLFOXIRI TREATMENT IN METASTATIC COLORECTAL CANCER PATIENTS PROGRESSED AFTER FIRST-LINE FOLFOXIRI
    Baldi, Giacomo Giulio
    Vasile, Enrico
    Masi, Gianluca
    Loupakis, Fotios
    Stasi, Irene
    Salvatore, Lisa
    Fornaro, Lorenzo
    Cupini, Samanta
    Pfanner, Elisabetta
    Brunetti, Isa Maura
    Di Donato, Samantha
    Caponi, Sara
    Allegrini, Giacomo
    Antonuzzo, Andrea
    Ricci, Sergio
    Andreuccetti, Michele
    Falcone, Alfredo
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [7] Reintroduction of FOLFOXIRI treatment in metastatic colorectal cancer patients progressed after first-line FOLFOXIRI
    Vasile, E.
    Masi, G.
    Loupakis, F.
    Cupini, S.
    Baldi, G. G.
    Salvatore, L.
    Fornaro, L.
    Pfanner, E.
    Ricci, S.
    Falcone, A.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 346 - 346
  • [8] FOLFOXIRI in metastatic colorectal cancer: A criticism from its native land
    Ottaiano, Alessandro
    Nasti, Guglielmo
    Cassata, Antonino
    De Stefano, Alfonso
    Caraglia, Michele
    Avallone, Antonio
    [J]. CANCER LETTERS, 2017, 408 : 71 - 72
  • [9] FOLFOXIRI therapy with bevacizumab in metastatic colorectal cancer patient: Systematic review
    Subroto, Dion Ravinder Theodeus
    Sutanto, Mario
    Law, Natasha Karlina
    Lee, Jonathan Vincent
    Kumar, Chandni
    Siregar, Axel Sebastian
    Sihombing, Andreas
    Ang, Xavier Manuel
    Kurniawan, Andree
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1459 - S1459
  • [10] Understanding the FOLFOXIRI-regimen to optimize treatment for metastatic colorectal cancer
    Sunakawa, Yu
    Schirripa, Marta
    Lenz, Heinz-Josef
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 100 : 117 - 126
12345